Molecular Imaging Agents to 2028


molecular imaging agents  Molecular Imaging Agents to 2028 • MJA577K • August 2022 • US$3,850


 

 

The ability of molecular imaging agents to improve diagnostic and treatment capabilities is now driving a directed effort to develop new agents with enhanced specificity. To sense biological processes such as gene expression, angiogenesis, apoptosis or cell trafficking in vivo, imaging reporter agents that interact specifically with molecular targets and appropriate imaging systems are currently under development. Molecular imaging will greatly reduce the need for animal tissue sampling or human biopsy when studying the progression of a disease or the follow-up of a gene therapy. It has the advantage of being non-invasive, and because it can be repeated many times, it provides both spatial and temporal dimensions to the understanding of the gene expression of the disease or therapy.

 

 
 
 
 
 
          Order Online HERE
 
 

Molecular Imaging Agents to 2028 – What You Will Learn

  • Analyzes molecular imaging agents by category, target and method of detection, and assesses their capabilities, benefits, limitations and potential
    • Examines evolving imaging market segments and their impact on the diagnostic imaging sector
    • Analyzes key industry alliances and partnerships by imaging modality, and examines the impact of next-generation imaging candidates on future imaging markets
    • Profiles market participants, their development activity and business strategies
    • Evaluates the impact of economic, technology, and regulatory factors on the development and commercialization of emerging imaging agents

 

Summary of Contents

Executive Summary
The Evolving Diagnostic Imaging Market
Imaging Agent Product Segments
Antibodies
Conjugated Radioisotopes
Metabolic Biomarkers
Optical Probes
Nanoparticles
Targeted Imaging Agents
Activatable Imaging Agents
Evolution in Imaging Agent Market Segments
Disease Detection
Image-Guided Drug Delivery
Physiological Process Mapping
Therapeutic Screening
Treatment Assessment
Differential Diagnosis
Molecular Imaging Agents & Imaging Modalities
MRI
Optical Imaging
PET
SPECT
Ultrasound
Agent Categories
Affibodies
Antibody Fragments
Antibodies Targeting Immune Factors
mAbs
Chimeric mAbs
Nanoparticles
Clinical Applications
Apoptosis
Cardiology
Angiogenesis
Adenosine Receptors
Vascular Endothelial Growth Factor Receptors
Immunology
Autoimmunity & Inflammation
Metabolic
Diabetes
Neurology
Amyloid Peptides
Peripheral Benzodiazepine Receptors
Dopamine Receptors
Metabotropic Glutamate
Norepinephrine Transporter
P-glycoprotein Transporter
Serotonin Receptors
Serotonin Transporter
Cannabinoid Receptors
Oncology
Estrogen Receptor
Glucose Transporters
L-Type Amino Acid Transporter
Matrix Metalloproteinase
Melanocortin-1
Prostate-specific Membrane Antigen (PSMA)
Sigma Receptors
Somatostatin Receptors
Market Factors
Guidance, Rules and Regulations
FDA
Company Profiles